Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 |Industry: Pharmaceuticals
|Expensive Star
154.40 5.35 (3.59%)
NSE Oct 21, 2020 12:29 PM
Volume: 628.3K

Sequent Scientific Ltd.    
19 Apr 2018
Nirmal Bang Institutional
Sequent Scientific (SSL) has announced its acquisition of Bremer Pharma, Germany, on 17 April 2018. Founded in 1982, Bremer Pharma is the animal health subsidiary of Zydus Cadila. With a paid-up capital of US$0.59mn, it reported top-line revenues of US$8.3mn with a marginal loss in FY17. With about 400 product registrations, Bremer Pharma supplies vitamins, antibiotics and hormones. The product registrations are across Europe, MENA region, Russia and Africa. Acquisition cost: Total EV is about US$2.8mn, of which the share purchase price is US$1.08mn and loan purchase price is US$1.72mn. This works out to EV/sales multiple of...
Sequent Scientific Ltd. is trading above all available SMAs
More from Sequent Scientific Ltd.